Allakos Inc.
ANTI-SIGLEC-7 ANTIBODIES HAVING REDUCED EFFECTOR FUNCTION

Last updated:

Abstract:

The invention provides methods and compositions for the treatment of cancer using anti-Siglec-7 antibodies that have reduced effector function.

Status:
Application
Type:

Utility

Filling date:

11 Jan 2019

Issue date:

25 Feb 2021